Glabridin arrests cell cycle and inhibits proliferation of hepatocellular carcinoma by suppressing braf/MEK signaling pathway.

MLA

Wang, Ziyou, et al. “Glabridin Arrests Cell Cycle and Inhibits Proliferation of Hepatocellular Carcinoma by Suppressing Braf/MEK Signaling Pathway.” Tumor Biology (Springer Science & Business Media B.V.), vol. 37, no. 5, May 2016, pp. 5837–46. EBSCOhost, https://doi.org/10.1007/s13277-015-4177-5.

APA

Wang, Z., Luo, S., Wan, Z., Chen, C., Zhang, X., Li, B., Huang, G., Chen, L., He, Z., & Huang, Z. (2016). Glabridin arrests cell cycle and inhibits proliferation of hepatocellular carcinoma by suppressing braf/MEK signaling pathway. Tumor Biology (Springer Science & Business Media B.V.), 37(5), 5837–5846. https://doi.org/10.1007/s13277-015-4177-5

Chicago

Wang, Ziyou, Shengqun Luo, Zheng Wan, Chuyan Chen, Xiangning Zhang, Binbin Li, GuoLiang Huang, Liyong Chen, Zhiwei He, and Zunnan Huang. 2016. “Glabridin Arrests Cell Cycle and Inhibits Proliferation of Hepatocellular Carcinoma by Suppressing Braf/MEK Signaling Pathway.” Tumor Biology (Springer Science & Business Media B.V.) 37 (5): 5837–46. doi:10.1007/s13277-015-4177-5.